行情

NURO

NURO

NeuroMetrix
NASDAQ

实时行情|Nasdaq Last Sale

3.362
-1.388
-29.22%
交易中 12:05 01/27 EST
开盘
3.150
昨收
4.750
最高
3.630
最低
3.080
成交量
54.61万
成交额
--
52周最高
12.00
52周最低
2.518
市值
328.88万
市盈率(TTM)
-0.0449
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

NURO 新闻

  • 通用汽车投资30亿美元生产全电动卡车和自动驾驶汽车
  • 新浪美股.1小时前
  • 尚乘蔡志坚与邱腾华等共同出席达沃斯"尚乘·湾区青年企业家日"
  • 新浪财经.1小时前
  • 英国首相发言人:首相办公室将牵头英国脱欧谈判
  • 新浪美股.1小时前
  • Mid-Morning Market Update: Markets Open Lower; D. R. Horton Earnings Top Views
  • Benzinga.1小时前

更多

所属板块

医疗设备、用品及经销
-0.16%
医疗设备和用品
-0.81%

热门股票

名称
价格
涨跌幅

NURO 简况

NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. The Company is engaged in the sale of medical equipment, and consumables and accessories. It has two principal product lines: Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. Its products include ADVANCE NCS/EMG System (the ADVANCE System), Quell, SENSUS and DPNCheck. Quell is a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems. The SENSUS pain therapy device, the technological predecessor to Quell, is a prescription neuro-stimulation device based on transcutaneous electrical nerve stimulation (TENS) for relief of chronic, intractable pain. DPNCheck is a quantitative nerve conduction test. ADVANCE System is a platform for the performance of traditional nerve conduction studies.
展开

Webull提供Neurometrix Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。